Sequential Integrated Screen, Part 1 (NY)

Sequential Integrated Screen, Part 1 (NY)

Test Code

16974
81508
16974
81508
This test is not available in all locations. Please provide SERVICE AREA INFORMATION to confirm Test Code for the lab that services your account or to find available tests you can order.
In-home collection is not available in your area through Quest Mobile.

Clinical Significance

Sequential Integrated Screen, Part 1 (NY) - To assess maternal risk for carrying a fetus with Down Syndrome (Trisomy 21) or Trisomy 18 in the first or second trimester, or a neural tube defect, when used in conjunction with the Part 2 testing. These types of tests are standard- of-care in obstetrics.

Test Resources

None found for this test
Please visit our Clinical Education Center to stay informed on any future publications, webinars, or other education opportunities.

Test Details

Methodology

Chemiluminescence (CL) • Immunoassay (IA)

Assay Category

PAPP-A: This test was performed using a kit that has not been cleared or approved by the FDA. The analytical performance characteristics of this test have been determined by Quest Diagnostics. This test should not be used for diagnosis without confirmation by other medically established means.

This test code is for New York patient testing. For non-New York patient testing, use test code 16131.

Reference Range(s)

See Laboratory Report

LOINC® Codes, Performing Laboratory

Methodology

Chemiluminescence (CL) • Immunoassay (IA)
PAPP-A: This test was performed using a kit that has not been cleared or approved by the FDA. The analytical performance characteristics of this test have been determined by Quest Diagnostics. This test should not be used for diagnosis without confirmation by other medically established means.

This test code is for New York patient testing. For non-New York patient testing, use test code 16131.

Reference Range(s)

See Laboratory Report

Preferred Specimen(s)

1.5 mL serum

Minimum Volume

0.8 mL

Collection Instructions

Collect between 10.0 weeks to 13.9 weeks. Must complete patient demographic information using the Maternal Serum Screen Requisition.

Additional information: NT measurement, when provided by the physician, will be used for additional interpretation.

Transport Container

Transport tube

Transport Temperature

Room temperature

Specimen Stability

  • Room temperature: 14 days
  • Refrigerated: 14 days
  • Frozen: 28 days

Reject Criteria

Gross hemolysis

Setup Schedule

1.5 mL serum
0.8 mL
Collect between 10.0 weeks to 13.9 weeks. Must complete patient demographic information using the Maternal Serum Screen Requisition.

Additional information: NT measurement, when provided by the physician, will be used for additional interpretation.
Transport tube

Room temperature

Room temperature: 14 days
Refrigerated: 14 days
Frozen: 28 days
Gross hemolysis
This test is not available in all locations. Please provide ACCOUNT INFORMATION NEEDED to confirm Test Code for the lab that services your account or to find available tests you can order.
In-home collection is not available in your area through Quest Mobile.
Test Details

Clinical Significance

Test Resources

Reference ranges are provided as general guidance only. To interpret test results use the reference range in the laboratory report.

The CPT codes provided are based on AMA guidance and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

This material contains content from LOINC® (http://loinc.org). The LOINC Table, LOINC Table Core are copyright © 1995-2019, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the license at http://loinc.org/license.

The tests listed by specialty and category are a select group of tests offered. For a complete list of Quest Diagnostics tests, please adjust the filter options chosen, or refer to our Directory of Services.